We may earn a commission if you sign up or buy through links on this page. This doesn’t affect our rankings, which follow our methodology.
This Found weight loss review checks whether Found is worth paying for in November 2026. Found is a legitimate telehealth program that bills clinical visits to commercial insurance, but its lowest prices require a 12-month prepaid plan and mostly cover compounded GLP-1s, which are not FDA-approved. Brand-name drugs cost extra.
We didn’t sign up as patients: we read Found’s public pages, terms and study on November 14, 2026, and scored it like all our telehealth program reviews.
Key takeaways in 30 seconds
- Found prices by 28-day cycle: a year holds 13 cycles, not 12.
- The bundled drug is compounded: the FDA does not review it for safety, effectiveness or quality.
- Only the membership fee is refundable, within 3 days of purchase or before your first consultation; shipped medication and renewals are not.
- Found’s own study shows 8.0 % average weight loss at 12 months, below the 12 % to 20 % in its marketing.
Contents
Found weight loss review: our verdict on 6 criteria
Found rates “Partly” on five of six criteria and “Falls short” on transparency. Scale (our methodology): Meets = clear and public; Partly = with gaps; Falls short = missing.
| Criterion | What we found | Rating |
|---|---|---|
| Real monthly cost | 28-day cycles, prepay, conflicting price lists | Partly |
| Medication type | Bundled drug compounded; brand-name drugs billed separately | Partly |
| Clinical care | Named medical groups, monthly contact; cash mostly text | Partly |
| Transparency | 3-day refund window, arbitration, pharmacy partners unnamed | Falls short |
| Safety | Clinician review; “microdosing,” peptide waitlist | Partly |
| Evidence | Company-funded, retrospective study | Partly |
Best for: commercially insured adults who want insurance-billed clinician visits and are ready for a long commitment, knowing the drug included in the price is compounded, not FDA-approved, and that FDA-approved drugs are billed separately.
Not for: people who want to use Medicare, Medicaid or TRICARE coverage (Found’s insurance pricing excludes them); anyone unsure they’ll stay a year.
How does Found weight loss work? Clinicians and check-ins
You complete an online assessment; a licensed clinician from Found’s named medical groups (Pippen Health, Cloud Health Medical Group or Openloop Healthcare Partners) reviews it and may prescribe. You then check in monthly for refills: video visits on insurance, care “text-based in most cases” on cash.
Compounded drugs come from US 503A pharmacies; brand-name drugs go to your pharmacy, NovoCare or LillyDirect.
Labs aren’t included in the plan price, and Found doesn’t publish clinician reply times or how dose changes are decided.
Our clinical-care rating: Partly. Real clinicians, but mostly text on cash.
Found weight loss cost: what you pay in November 2026
Found’s cheapest prices, $79 per 28-day cycle with insurance and $149 cash, require a 12-month compounded semaglutide plan paid up front.
Found membership cost per 28-day cycle, as of November 14, 2026
| Plan (1 / 3 / 6 / 12 months) | Insurance track* | Cash track | Medication |
|---|---|---|---|
| Compounded semaglutide | $199 (1st cycle $79) / $119 / $99 / $79 | $269 (1st $149) / $199 / $179 / $149 | Included, compounded |
| Compounded tirzepatide | $289 (1st $149) / $199 / $179 / $149 | $339 (1st $199) / $269 / $249 / $199 | Included, compounded |
| Branded GLP-1 or Generics plan (oral, non-GLP-1) | $89 / $79 / $69 / $49 | $149 / $139 / $129 / $99 | Branded extra; generics included |
*Plus a copay. Compounded rows: store pages; others: offer terms, which (updated August 26, 2025) list higher 12-month compounded prices: $99 insurance and $169 cash for semaglutide, $179 and $239 for tirzepatide.
What a year really costs
Our method (estimate): 13 cycles of 28 days; Found’s “12 months” is 48 weeks, so we add a renewal cycle at the same rate (Found publishes no renewal price). On insurance, we assume one billed video visit per cycle at the “typically around $30” copay; your costs may differ. Labs and taxes excluded.
| Scenario, as of November 14, 2026 | Year 1 (13 cycles) |
|---|---|
| Compounded semaglutide, insurance, 12-month plan | $79 × 13 + $390 copays = $1,417 |
| Compounded semaglutide, cash, 12-month plan | $149 × 13 = $1,937 ($2,197 at the offer-terms $169) |
| Compounded semaglutide, cash, month-to-month | $149 + 12 × $269 = $3,377 |
| Compounded tirzepatide, cash, 12-month plan | $199 × 13 = $2,587 |
| Compounded tirzepatide, cash, month-to-month | $199 + 12 × $339 = $4,267 |
| Branded plan, cash, 12 months + Zepbound® (LillyDirect) | $99 × 13 + $299 + 12 × $399 = $6,374 at the 5 mg maintenance dose; higher doses cost more |
Zepbound’s 2.5 mg starting dose ($299) is used only for the first 4 weeks; the label doesn’t approve it as a maintenance dose.
Lower compounded totals don’t buy the same thing: these drugs aren’t FDA-approved.
Before you prepay 12 months
A cash 12-month compounded semaglutide plan means about $1,788 up front ($149 × 12, our estimate). Only the membership part is refundable, under the short window in the fine-print table, and shipped medication is not.
Found’s tiles quote Zepbound® “from $650/mo+”; its Zepbound page says $299. Compare the cheapest GLP-1 without insurance or our GLP-1 cost calculator. Current plans: Found’s pricing page.
Our rating: Partly. Public prices, blurred by prepay and conflicting lists.
Brand-name or compounded: which medications Found prescribes
Found’s GLP-1 plan price includes only compounded medication; approved brand-name drugs are prescribed but paid separately.
- Compounded semaglutide or tirzepatide with B12/glycine, included. The added ingredients make it a different product from Wegovy® or Zepbound®, not a generic.
- Brand-name weight-management drugs: Wegovy®, Zepbound®, Foundayo® and Saxenda®. Found also lists Ozempic® and Mounjaro®, approved for type 2 diabetes (off-label for weight).
- A Generics plan that includes “certain” oral non-GLP-1 generics; Found’s site lists metformin, topiramate and zonisamide (off-label for weight). It also prescribes brand-name Contrave® (naltrexone-bupropion), approved for chronic weight management; its label carries a boxed warning about suicidal thoughts and behaviors. Topiramate can harm a developing baby, so tell your clinician if you could become pregnant.
Compounded means not FDA-approved
The FDA’s page on unapproved GLP-1 drugs (checked November 14, 2026) says the agency does not review compounded drugs for safety, effectiveness or quality, and that they should only be used when an FDA-approved drug can’t meet a patient’s medical needs. As of May 31, 2026, it had received 990 adverse-event reports for compounded semaglutide and more than 730 for compounded tirzepatide, likely underreported.
The FDA declared the tirzepatide shortage resolved on December 19, 2024, and the semaglutide shortage on February 21, 2025, and its temporary flexibility for state-licensed (503A) pharmacies compounding them has ended (page current as of April 1, 2026).
What the evidence says. Wegovy®, Zepbound®, Foundayo®, Saxenda® and Contrave®: strong (grade A), FDA-approved for chronic weight management after randomized trials. Metformin, topiramate or zonisamide alone: moderate at best (grade B), with smaller losses in trials and no FDA approval for weight. Compounded semaglutide or tirzepatide: none for these specific products (grade D); the brand-name trials don’t transfer to them. “Microdosing” and the BPC-157, GHK-Cu and MOTS-c peptides: none for weight loss (grade D); we found no published human trial. Found’s own program: weak (grade C), one retrospective, company-funded study.
Our rating: Partly. The bundled drug is compounded.
Does Found weight loss take insurance?
Yes, for clinical visits with in-network commercial plans. Found’s billing consent calls the membership fee and compounded drugs “Non-Covered Services.”
- Government plans: insurance pricing is “not available” with Medicare, Medicaid, TRICARE or Medi-Cal. On Medicare, see the Medicare GLP-1 Bridge.
- Visits carry a copay, “typically around $30”; copays are non-refundable.
- Brand-name drugs may go through your pharmacy benefit, depending on your plan.
How to cancel Found, refunds and the fine print
Cancel any time by emailing support@joinfound.com or via “Cancel Membership” in the app, effective within 24 hours.
| Rule | What Found’s documents say | Source |
|---|---|---|
| Refund window | Membership fee only, if you cancel within 3 days or before the first consultation | Offer terms (Aug 26, 2025) |
| Renewals | Non-refundable; Found recommends cancelling at least 48 hours before | Offer terms |
| Medication | Non-refundable, non-returnable once shipped | Offer terms |
| No-show | $30 under 24 hours’ notice | Billing consent (Jul 1, 2026) |
| After cancelling | Provider and prescription access suspended that day | Terms (Nov 13, 2024) |
| Disputes | Binding individual arbitration (Miami, or within 100 miles of your home if Miami is farther); opt out by mail within 30 days | Terms §25-26 |
Medication access stops when you cancel, so plan it with your clinician. Found’s documents (2024 to 2026) don’t match store prices, and we found no public page naming its pharmacy partners.
Our rating: Falls short. The rules favor Found, and its documents contradict each other.
Is Found safe? Screening, microdosing and peptides
Two newer Found offers go beyond the evidence.
“Microdosing.” Found’s page offers weekly compounded semaglutide, which is not FDA-approved, with “lower starting weights now accepted,” and names no study. FDA-approved Wegovy is labeled for weight reduction in adults with obesity (BMI 30 or more) or overweight (BMI 27 or more) with at least one weight-related condition, and in teens 12 and older with obesity. Prescribing below those thresholds would be outside the approved use, and we found no published trial of “microdosing” for weight loss; anyone with a history of an eating disorder should raise it with a clinician first.
Peptide waitlist. Found lists BPC-157, MOTS-c and GHK-Cu as “launching soon.” None is FDA-approved, and the FDA’s page on bulk substances that may present significant safety risks (current as of April 22, 2026) lists all three among substances nominated for compounding and then withdrawn, noting a possible immune-reaction risk with BPC-157 and injectable GHK-Cu, and no human exposure data for MOTS-c.
Safety first: what the labels say
From the Wegovy, Zepbound, Foundayo and Saxenda labels:
- Boxed warning: don’t use them if you or a family member had medullary thyroid cancer (MTC), or if you have MEN 2, a rare inherited syndrome.
- Pregnancy: the labels say to discontinue when pregnancy is recognized (Wegovy: at least 2 months before a planned pregnancy); talk to your clinician if pregnant, planning it or breastfeeding. The Zepbound and Foundayo labels add that birth-control pills may work less well for several weeks after starting and after each dose increase, so ask about a non-pill or backup method.
- Under 18: Zepbound and Foundayo are for adults; Wegovy injection and Saxenda are also approved for some teens 12 and older.
- Tell your clinician about pancreatitis, gallbladder or kidney disease, or insulin or sulfonylurea use, and, beyond the labels, any history of an eating disorder.
- Never share an injection pen, even with a new needle.
- Compounded injections: the FDA has received reports of dosing errors with compounded semaglutide, some requiring hospitalization. Ask your clinician or pharmacist to show you how to measure each dose.
More in side effects and safety.
Our rating: Partly. Standard screening; microdosing and peptides outrun the evidence.
Does Found weight loss work? What the evidence shows
Found’s best evidence, a 2025 study in Obesity Science & Practice, found that members who still had a weight recorded at 12 months had lost 8.0 % of body weight on average. It is retrospective (based on past records), funded by Found, and co-written by Found employees. It covers 2021-2023 members on a range of medications, not specifically today’s compounded plans.
| Source | Figure | What it can and can’t tell you |
|---|---|---|
| Peer-reviewed study (66,094 members enrolled 2021-2023, 91.5 % women; 8,799 with 12-month data) | 8.0 % mean at 12 months; 64.2 % lost ≥ 5 %; weekly weight-loggers 12.0 % | No control group; only members with follow-up weights |
| Found website | 12 %, 1,773 weekly self-reporters | Self-reported, most engaged users |
| Headline claims | “16% on average,” “up to 20%” | Marketing, not clinical evidence |
Drug trial results belong to the drugs, not Found; see our GLP-1 weight loss calculator. Results vary.
Our rating: Partly. Rare published data, but company-funded and below the marketing.
Is Found legit? Complaints, BBB and customer reviews
Found Health, Inc. is a real company; complaints (customer accounts, not findings) center on billing, refunds and support. As of November 14, 2026:
- BBB: A+, accredited since April 29, 2024; 80 complaints in 3 years, 48 in the last 12 months (BBB profile). The grade ignores customer reviews.
- Trustpilot: 4.3 from 783 reviews, 71 % five-star, 18 % one-star (Trustpilot). Found invites reviews; none we saw was labeled “Verified.”
- Regulators: our searches found no FDA warning letter or FTC action naming Found as of November 14, 2026 (not a guarantee).
What to read next
- Cheapest GLP-1 without insurance: manufacturer prices.
- Weight-loss program prices: Found next to 14 other programs.
Frequently asked questions
Does Found offer a GLP-1 pill?
Yes, by prescription, with the drug billed separately. Found lists Foundayo®, an FDA-approved weight-management pill, and Rybelsus®, approved for type 2 diabetes (off-label for weight). See Foundayo vs Wegovy pill.
Is there a joinfound discount code?
We found no verified code; as of November 14, 2026, Found advertises “up to $100 off” membership and a cheaper first cycle on monthly plans.
Is Found weight loss FDA-approved?
No: the FDA approves drugs, not telehealth companies. Found can prescribe FDA-approved Wegovy® or Zepbound®, but the medication included in its plans is compounded and not FDA-approved.
Conclusion
Our Found weight loss review lands on “Partly”: real clinicians, but a long prepay, a compounded, not FDA-approved bundled drug and strict refunds. Ask your clinician which medication fits you.
For information only; not a substitute for your healthcare provider’s advice. Talk to your doctor before starting, stopping or changing any medication. Method: we did not sign up as patients; prices and safety statements were checked against Found’s pages and FDA sources on November 14, 2026.
